Form 4 · Filed Jun 11, 2026, 12:26 AM UTC
CVKD/Cadrenal Therapeutics, Inc.
Pham Quang X — Chairman, CEO and Interim CFO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | S | sell | 3,500 | $4 | $14,735 | 150,839 |
| Jun 9, 2026 | S | sell | 12,992 | $4 | $52,748 | 154,339 |
| Jun 8, 2026 | S | sell | 5,893 | $4 | $25,811 | 167,331 |
Source: SEC EDGAR raw filing ↗ · Accession 0001213900-26-067484